AMA submission to the National Medicines Policy Consultation Draft
The AMA supports the review of the National Medicines Policy (NMP) as an important long-term process.
In the initial submission on the review, the AMA noted that the objectives of the NMP are still relevant, however many were going unmet. The AMA recommended developing set of Key Performance Indicators to ensure Australia is meeting these objectives.
Other key recommendations included reinstating a national medicines advisory body to ensure the NMP remains relevant, and to monitor NMP policies and programs, and introducing new objectives that recognises how Australia’s broader health environment influences medicines use in Australia.
While positive developments were made, in general the lack of meaningful governance and reporting mechanisms mean this policy is not yet ready. The AMA supports the calls to complete this policy review after the upcoming Federal Election to ensure it is not rushed.
This document presents the AMA’s responses to questions asked in the format of an online survey.
The AMA made an earlier submission to the National Medicines Policy Review which is available here.
